GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (FRA:PGO0) » Definitions » PB Ratio

Prostatype Genomics AB (FRA:PGO0) PB Ratio : 0.59 (As of Apr. 07, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Prostatype Genomics AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-07), Prostatype Genomics AB's share price is €0.254. Prostatype Genomics AB's Book Value per Share for the quarter that ended in Dec. 2024 was €0.43. Hence, Prostatype Genomics AB's PB Ratio of today is 0.59.

Warning Sign:

Prostatype Genomics AB stock PB Ratio (=0.74) is close to 1-year high of 0.74.

The historical rank and industry rank for Prostatype Genomics AB's PB Ratio or its related term are showing as below:

FRA:PGO0' s PB Ratio Range Over the Past 10 Years
Min: 0.05   Med: 1.39   Max: 9.23
Current: 0.74

During the past 6 years, Prostatype Genomics AB's highest PB Ratio was 9.23. The lowest was 0.05. And the median was 1.39.

FRA:PGO0's PB Ratio is ranked better than
83.74% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.91 vs FRA:PGO0: 0.74

During the past 12 months, Prostatype Genomics AB's average Book Value Per Share Growth Rate was -92.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -72.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -34.80% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Prostatype Genomics AB was 19.40% per year. The lowest was -72.50% per year. And the median was -12.30% per year.

Back to Basics: PB Ratio


Prostatype Genomics AB PB Ratio Historical Data

The historical data trend for Prostatype Genomics AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB PB Ratio Chart

Prostatype Genomics AB Annual Data
Trend Jun18 Jun19 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial - 5.51 2.52 1.13 1.49

Prostatype Genomics AB Quarterly Data
Jun18 Jun19 Mar20 Jun20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 1.86 1.13 1.78 1.49

Competitive Comparison of Prostatype Genomics AB's PB Ratio

For the Diagnostics & Research subindustry, Prostatype Genomics AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prostatype Genomics AB's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's PB Ratio falls into.


;
;

Prostatype Genomics AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Prostatype Genomics AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=0.254/0.434
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Prostatype Genomics AB  (FRA:PGO0) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Prostatype Genomics AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prostatype Genomics AB Business Description

Traded in Other Exchanges
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines